Intraoperative subcutaneous or intrasplenic vaccination with modified autologous tumor cells leads to enhanced survival in a mouse tumor model.

Source:http://linkedlifedata.com/resource/pubmed/id/16395592

Download in:

View as

General Info

PMID
16395592